Unknown

Dataset Information

0

De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder.


ABSTRACT: POU3F3, also referred to as Brain-1, is a well-known transcription factor involved in the development of the central nervous system, but it has not previously been associated with a neurodevelopmental disorder. Here, we report the identification of 19 individuals with heterozygous POU3F3 disruptions, most of which are de novo variants. All individuals had developmental delays and/or intellectual disability and impairments in speech and language skills. Thirteen individuals had characteristic low-set, prominent, and/or cupped ears. Brain abnormalities were observed in seven of eleven MRI reports. POU3F3 is an intronless gene, insensitive to nonsense-mediated decay, and 13 individuals carried protein-truncating variants. All truncating variants that we tested in cellular models led to aberrant subcellular localization of the encoded protein. Luciferase assays demonstrated negative effects of these alleles on transcriptional activation of a reporter with a FOXP2-derived binding motif. In addition to the loss-of-function variants, five individuals had missense variants that clustered at specific positions within the functional domains, and one small in-frame deletion was identified. Two missense variants showed reduced transactivation capacity in our assays, whereas one variant displayed gain-of-function effects, suggesting a distinct pathophysiological mechanism. In bioluminescence resonance energy transfer (BRET) interaction assays, all the truncated POU3F3 versions that we tested had significantly impaired dimerization capacities, whereas all missense variants showed unaffected dimerization with wild-type POU3F3. Taken together, our identification and functional cell-based analyses of pathogenic variants in POU3F3, coupled with a clinical characterization, implicate disruptions of this gene in a characteristic neurodevelopmental disorder.

SUBMITTER: Snijders Blok L 

PROVIDER: S-EPMC6698880 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder.

Snijders Blok Lot L   Kleefstra Tjitske T   Venselaar Hanka H   Maas Saskia S   Kroes Hester Y HY   Lachmeijer Augusta M A AMA   van Gassen Koen L I KLI   Firth Helen V HV   Tomkins Susan S   Bodek Simon S   Õunap Katrin K   Wojcik Monica H MH   Cunniff Christopher C   Bergstrom Katherine K   Powis Zoë Z   Tang Sha S   Shinde Deepali N DN   Au Catherine C   Iglesias Alejandro D AD   Izumi Kosuke K   Leonard Jacqueline J   Abou Tayoun Ahmad A   Baker Samuel W SW   Tartaglia Marco M   Niceta Marcello M   Dentici Maria Lisa ML   Okamoto Nobuhiko N   Miyake Noriko N   Matsumoto Naomichi N   Vitobello Antonio A   Faivre Laurence L   Philippe Christophe C   Gilissen Christian C   Wiel Laurens L   Pfundt Rolph R   Deriziotis Pelagia P   Brunner Han G HG   Fisher Simon E SE  

American journal of human genetics 20190711 2


POU3F3, also referred to as Brain-1, is a well-known transcription factor involved in the development of the central nervous system, but it has not previously been associated with a neurodevelopmental disorder. Here, we report the identification of 19 individuals with heterozygous POU3F3 disruptions, most of which are de novo variants. All individuals had developmental delays and/or intellectual disability and impairments in speech and language skills. Thirteen individuals had characteristic low  ...[more]

Similar Datasets

| S-EPMC6871531 | biostudies-literature
| S-EPMC7907856 | biostudies-literature
| S-EPMC6128244 | biostudies-literature
| S-EPMC5673606 | biostudies-literature
| S-EPMC6612514 | biostudies-literature
| S-EPMC5223060 | biostudies-literature
| S-EPMC5846454 | biostudies-literature
| S-EPMC7058825 | biostudies-literature
| S-EPMC5630160 | biostudies-literature
| S-EPMC8322935 | biostudies-literature